Profil
Richard Novak was the founder of Rhinostics, Inc. where he held the title of Director.
He was also the founder of Unravel Biosciences, Inc. where he held the titles of President, Chief Executive Officer & Director.
Postes actifs de Richard Novak
| Sociétés | Poste | Début |
|---|---|---|
Rhinostics, Inc.
 Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Rhinostics, Inc. is a company that revolutionizes swab-based sample processing workflows worldwide. The company is based in Brookline, MA. The company offers simple and elegant swab solutions that bring efficiencies and cost savings to laboratory workflows. The company's flagship product, the Rhinostic automated nasal swab, is designed to work in an automated workflow and offers a robust and consistent 10x sample throughput increase compared to manual methods. Rhinostics products are registered as class I exempt medical devices with the FDA and may be used for clinical collection upon CLIA validation. The company was founded by Michael Springer and Richard Novak. The CEO is Cheri L. Walker. | Fondateur | - |
Unravel Biosciences, Inc.
 Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Rhinostics, Inc. is a company that revolutionizes swab-based sample processing workflows worldwide. The company is based in Brookline, MA. The company offers simple and elegant swab solutions that bring efficiencies and cost savings to laboratory workflows. The company's flagship product, the Rhinostic automated nasal swab, is designed to work in an automated workflow and offers a robust and consistent 10x sample throughput increase compared to manual methods. Rhinostics products are registered as class I exempt medical devices with the FDA and may be used for clinical collection upon CLIA validation. The company was founded by Michael Springer and Richard Novak. The CEO is Cheri L. Walker. | Commercial Services |
Unravel Biosciences, Inc.
Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation. | Health Technology |
